Search research articles
Contact Us
Filters
Showing results (81-90 of 91) with videos related to
Page
of 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 22, 2016
Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II Trial
Nick Pavlakis, Katrin M Sjoquist, Andrew J Martin, et al.
Nature Communications
|
October 6, 2025
Inflammation and mutational burden differentially associated with nivolumab or ipilimumab combination efficacy in colorectal cancer
Ming Lei, Michael J Overman, Jin Yao, et al.
Neuro-Oncology Practice
|
October 13, 2025
Clinical outcomes and management of <i>CDKN2A/B</i> homozygously deleted IDH-mutant astrocytomas-a cohort study and patterns of care survey
Alexander Yuile, Laveniya Satgunaseelan, Kimberley L Alexander, et al.
The Lancet. Oncology
|
December 7, 2017
Go, no-go decision making for phase 3 clinical trials: ACT IV revisited - Authors' reply
Michael Weller, Nicholas Butowski, David D Tran, et al.
The Lancet. Oncology
|
August 29, 2017
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
Michael Weller, Nicholas Butowski, David D Tran, et al.
Plos One
|
December 31, 2025
How much is too much? A medication use evaluation of VA ICU sedation practice during the COVID-19 pandemic
Ian C Murphy, Kelly Bryan, Muriel Burk, et al.
Ejhaem
|
August 19, 2024
Sequential high-dose methotrexate and cytarabine administration improves outcomes in real-world patients with primary central nervous system lymphoma: A report from the Australasian Lymphoma Alliance
Maciej Tatarczuch, Katharine Louise Lewis, Ashray Gunjur, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 19, 2016
TTI-621 (SIRPαFc): A CD47-Blocking Innate Immune Checkpoint Inhibitor with Broad Antitumor Activity and Minimal Erythrocyte Binding
Penka S Petrova, Natasja Nielsen Viller, Mark Wong, et al.
BMC Cancer
|
January 29, 2025
Solving unknown primary cancer with earlier diagnosis - the SUPER-ED trial: study protocol for a stepped-wedge cluster randomised controlled trial to support earlier diagnosis for people presenting with malignancy of undefined primary origin
Anna Ugalde, Richard W Tothill, Stephen Quinn, et al.
Ecological Applications : a Publication of the Ecological Society of America
|
April 17, 2024
Effectiveness of population-based recovery actions for threatened southern mountain caribou
Clayton T Lamb, Sara Williams, Stan Boutin, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 91) with videos related to
Sort By:
Page
of 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 22, 2016
Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II Trial
Nick Pavlakis, Katrin M Sjoquist, Andrew J Martin, et al.
Nature Communications
|
October 6, 2025
Inflammation and mutational burden differentially associated with nivolumab or ipilimumab combination efficacy in colorectal cancer
Ming Lei, Michael J Overman, Jin Yao, et al.
Neuro-Oncology Practice
|
October 13, 2025
Clinical outcomes and management of <i>CDKN2A/B</i> homozygously deleted IDH-mutant astrocytomas-a cohort study and patterns of care survey
Alexander Yuile, Laveniya Satgunaseelan, Kimberley L Alexander, et al.
The Lancet. Oncology
|
December 7, 2017
Go, no-go decision making for phase 3 clinical trials: ACT IV revisited - Authors' reply
Michael Weller, Nicholas Butowski, David D Tran, et al.
The Lancet. Oncology
|
August 29, 2017
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
Michael Weller, Nicholas Butowski, David D Tran, et al.
Plos One
|
December 31, 2025
How much is too much? A medication use evaluation of VA ICU sedation practice during the COVID-19 pandemic
Ian C Murphy, Kelly Bryan, Muriel Burk, et al.
Ejhaem
|
August 19, 2024
Sequential high-dose methotrexate and cytarabine administration improves outcomes in real-world patients with primary central nervous system lymphoma: A report from the Australasian Lymphoma Alliance
Maciej Tatarczuch, Katharine Louise Lewis, Ashray Gunjur, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 19, 2016
TTI-621 (SIRPαFc): A CD47-Blocking Innate Immune Checkpoint Inhibitor with Broad Antitumor Activity and Minimal Erythrocyte Binding
Penka S Petrova, Natasja Nielsen Viller, Mark Wong, et al.
BMC Cancer
|
January 29, 2025
Solving unknown primary cancer with earlier diagnosis - the SUPER-ED trial: study protocol for a stepped-wedge cluster randomised controlled trial to support earlier diagnosis for people presenting with malignancy of undefined primary origin
Anna Ugalde, Richard W Tothill, Stephen Quinn, et al.
Ecological Applications : a Publication of the Ecological Society of America
|
April 17, 2024
Effectiveness of population-based recovery actions for threatened southern mountain caribou
Clayton T Lamb, Sara Williams, Stan Boutin, et al.
Page
of 10